Skip to main content

MoneyWorks4Me

Glenmark Pharmaceuticals submits copy of press release

23 Oct 2015 Evaluate

Glenmark Pharmaceuticals has submitted a copy of press release dated October 23, 2015 titled ‘Glenmark announces Strategic Development & Licensing Agreement with Celon, Poland for generic Seretide Accuhaler in Europe’

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1771.95
Dr. Reddys Labs. 1370.00
Cipla 1392.20
Lupin 2012.00
Zydus Lifesciences 1239.00
View more..